Contact A Counsellor

counsellor button


teen suicide icon


panic anxiety icon

panic anxiety icon

#MindfulMondays with Miss SA

teen suicide icon


Research on Depression in the Workplace.

For more information please click here



email subscribers list

To subscribe to SADAG's newsletter, click here

To view previous newsletters - click here


Mental Health Matters Journal for Psychiatrists & GP's

MHM Volume 8 Issue1

Click here for more info


journalists crew making newspaper

If you are a journalist writing a story contact Kayla on 011 234 4837  media@anxiety.org.za


MySchool Facebook banner Nov

It’s the small things that make a BIG difference. Sign up for the “My School | My Village | My Planet” Card and start making a difference to Mental Health in South Africa today.

Click Here


cope with cancer book

Literacy is a luxury that many of us take for granted. That is why SADAG created SPEAKING BOOKS and revolutionized the way healthcare information is delivered to low literacy communities.

The customizable 16-page book, read by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood by everyone across the world.

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 100+ titles, such as TB, Malaria, Polio, Vaccines for over 45 countries.

suicide speaking book

(Ivanhoe Newswire) -- According to a study conducted at University of Rochester Center in N.Y., patients who are taking clozapine, the most effective antipsychotic drug, have significantly higher rates of metabolic syndrome.Metabolic syndrome is a group of conditions that can increase the risk for diabetes, stroke, and heart disease. Some of the conditions include high blood pressure, insulin resistance, abnormal levels of cholesterol and triglycerides, and excess body fat around the waist. Patients with metabolic syndrome are usually at two- to three-times greater risk for cardiovascular disease-related mortality. Clozapine is recommended for patients resistant to conventional antipsychotic drugs. Currently, it is the only medication approved by the Food and Drug Administration for the treatment of suicidal behavior. There are potential benefits to taking this drug, but researchers now say the increased physical health risks must also be taken into consideration.In this study, 2,700 psychiatry patients were weighed, measured and tested for diabetes, blood lipids, and blood pressure. The research showed that over 50 percent of the patients taking clozapine for at least six months had metabolic syndrome. In a comparison group not taking clozapine, only 20 percent had metabolic syndrome. There have been many studies showing that clozapine is associated with weight gain and agranulocytosis -- a serious blood disease, but this is the first study to further describe clozapine's link to metabolic syndrome.J. Steven Lamberti, M.D., says, "There are long-term health implications (with clozapine). This study suggests that patients who need the most effective medication are between a rock and a hard place."This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.


Our Sponsors

Our Partners